Anika Therapeutics announced that its Integrity Implant System is now in full market release and broadly available across the U.S. The Integrity System, comprised of a hyaluronic acid-based implant with bone and tendon fixation components and innovative single use arthroscopic delivery instruments, is designed to protect an injured tendon and promote healing in rotator cuff repair and other tendon procedures. The system has been in limited release since November 2023.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANIK:
- Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Anika Therapeutics Expands Board, Launches Buyback Program
- Anika Enters into Cooperation Agreement with Caligan Partners
- Anika Therapeutics announces $40M share repurchase program
- Anika enters cooperation pact with Caligan, appoints two new directors to board